Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials

Mesenchymal Stem Cells in Multiple Sclerosis (MSCIMS)

This study has been completed.
Sponsor:
Collaborators:
Cambridge University Hospitals NHS Foundation Trust
Medical Research Council
Information provided by (Responsible Party):
Peter Connick, University of Cambridge
ClinicalTrials.gov Identifier:
NCT00395200
First received: November 1, 2006
Last updated: October 22, 2011
Last verified: October 2011
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study has been completed.
  Study Completion Date: December 2010
  Primary Completion Date: December 2010 (Final data collection date for primary outcome measure)